Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling

AIMS: In patients at high risk of heart failure following myocardial infarction (MI) as a result of residual left ventricular systolic dysfunction (LVSD), the angiotensin receptor neprilysin inhibitor sacubitril/valsartan may result in a greater attenuation of adverse left ventricular (LV) remodelli...

Descripción completa

Detalles Bibliográficos
Autores principales: Docherty, Kieran F., Campbell, Ross T., Brooksbank, Katriona J.M., Godeseth, Rosemary L., Forsyth, Paul, McConnachie, Alex, Roditi, Giles, Stanley, Bethany, Welsh, Paul, Jhund, Pardeep S., Petrie, Mark C., McMurray, John J.V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835504/
https://www.ncbi.nlm.nih.gov/pubmed/33305513
http://dx.doi.org/10.1002/ehf2.13137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835504/
https://www.ncbi.nlm.nih.gov/pubmed/33305513
http://dx.doi.org/10.1002/ehf2.13137

Ejemplares similares